Market Overview

UPDATE: Jefferies Raises PT on Cerner Corporation on Competitive Inroads

Related CERN
Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Highest Revenue
#PreMarket Primer: Thursday, September 4: Talk Of A Ceasefire In Ukraine
Making Money With Charles Payne: 10/22/14 (Fox Business)

In a report published Friday, Jefferies analyst David Windley reiterated a Buy rating on Cerner Corporation (NASDAQ: CERN), and raised the price target from $97.00 to $110.00.

In the report, Windley noted, “In recent presentations, KLAS (HCIT independent rating org) described current competitive trends in the EHR space, and Premier (GPO) members forecasted continued high IT spending. Epic is still the dominant player, but CERN is making competitive inroads with decision makers; raising CERN PT to $110. ATHN has higher stickiness and promoter scores than industry averages. MDRX has fallen off clients' radars, and has a lot of work to do.”

Cerner Corporation closed on Thursday at $95.54.

Latest Ratings for CERN

DateFirmActionFromTo
Oct 2014Credit SuisseMaintainsNeutral
Sep 2014Topeka CapitalMaintainsBuy
Aug 2014Wells FargoUpgradesMarket PerformOutperform

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CERN)

Around the Web, We're Loving...

Get Benzinga's Newsletters